Traders try to evaluate the possibility of additional sanctions on Russia.

The Investment Committee give you their top stocks to watch for the second half.

SOUN posts 217% revenue surge and expands to 14,000+ QSRs, but rivals like AMZN and GOOGL loom large in the restaurant AI race.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. (“Exelixis” or the “Company”) (NASDAQ: EXEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. (“Praxis” or the “Company”) (NASDAQ: PRAX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Vanguard Consumer Staples ETF hits a 52-week high, climbing 11.71% off its low as investors seek safety in volatile markets.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Albany International Corp. (“Albany” or the “Company”) (NYSE: AIN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tronox Holdings plc (“Tronox” or the “Company”) (NYSE: TROX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Insperity, Inc. (“Insperity” or the “Company”) (NYSE: NSP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Company Categorically Rejects All Allegations Which it Believes to be False, Misleading and Malicious Company Reaffirms Recently Increased Full Year 2025 Guidance Miami, FL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today issued the following statement in response claims made in a short seller report: Tecnoglass categorically rejects what it believes are false, misleading, and unsubstantiated allegations contained in the report. Tecnoglass believes the publication is a clear attempt to manipulate the market …

A fairly consistent climb in Tilray Brands' NASDAQ: TLRY stock price has started to capture the market's attention. After touching a 52-week low of 35 cents, the stock has rallied dramatically, climbing over 133% in the last three months on massive trading volume.

Meta Platforms' (META) FQ2 earnings report and latest AI restructuring effort reflect near-term uncertainties. The company's robust core ad business, AI advancements, and pipeline products (e.g., the Hypernova smart glasses) support double-digit EPS growth rates. The long-term reward/risk ratio is further skewed thanks to other compounding forces afoot.

CMG's loyalty base hit 20 million, with new promotions boosting engagement as comps struggle in 2025.

BILLERICA, Mass.--(BUSINESS WIRE)--Entegris, Inc. (Nasdaq: ENTG), a global leader in advanced materials science, in collaboration with the Trump Administration, today announced $700 million in domestic R&D spending over the next several years to accelerate semiconductor innovation. This investment in R&D projects and related capital expenditures will span its two divisions, Materials Solutions and Advanced Purity Solutions. A portion of this investment will be used to develop its Aurora.

Medtronic delivered solid earnings, with standout growth in Cardiovascular, but overall performance remains mixed due to weaker Neuroscience and MedSurg segments. Elliott Management's activist involvement and new board appointments could drive operational improvements and strategic divestitures, echoing past success at Cardinal Health. Valuation is attractive on a PEG basis, but I remain on hold, awaiting clear evidence of sustainable earnings momentum and operational execution.